CAG
BIIB icon

Crestwood Advisors Group’s Biogen BIIB Stock Holding History

Crestwood Advisors Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$589K Buy
2,725
+244
+10% +$46.7K 0.01% 441
2026
Q1 		$455K Buy
2,481
+287
+13% +$52.9K 0.01% 446
2025
Q4 		$386K Buy
2,194
+373
+20% +$60.9K 0.01% 449
2025
Q3 		$255K Buy
+1,821
New +$246K ﹤0.01% 499
2017
Q2 		– Sell
-386
Closed -$105K – 187
2017
Q1 		$105K Buy
+386
New +$109K 0.01% 190
2015
Q4 		– Sell
-975
Closed -$285K – 151
2015
Q3 		$285K Hold
975
– – 0.04% 119
2015
Q2 		$394K Sell
975
-16
-2% -$6.42K 0.05% 100
2015
Q1 		$418K Buy
991
+214
+28% +$84.3K 0.06% 88
2014
Q4 		$264K Buy
+777
New +$251K 0.04% 112

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Crestwood Advisors Group's BIIB Position: Q2 2026 in Review

Crestwood Advisors Group increased its Biogen (BIIB) stake by 9.8% in Q2 2026, buying an estimated $46.7K and bringing the position to 2,725 shares worth $589K. The position accounts for 0.01% of the portfolio, ranked #441.

Crestwood Advisors Group first reported a position in BIIB in Q4 2014 and has held it in 9 quarters since. 1,038 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Crestwood Advisors Group held 2,725 shares of Biogen worth $589K as of Q2 2026.
  • Crestwood Advisors Group bought 244 Biogen shares in Q2 2026, an estimated $46.7K.
  • Biogen made up 0.01% of Crestwood Advisors Group's portfolio in Q2 2026, its #441 holding.
  • Crestwood Advisors Group first reported a position in Biogen in Q4 2014 and has held it in 9 quarters since.
  • 1,038 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Crestwood Advisors Group's 13F filing for Q2 2026, filed 3 Aug 2026.